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Abstract 
 
Exclusive Enteral Nutrition (EEN) is commonly used in the management of Crohn's 
disease (CD). Polymeric formulae (PF), comprising whole proteins along with the daily 
requirements of vitamins and minerals, are commonly used for EEN. The mechanism 
by which several weeks of PF treatment induces remission is incompletely understood 
and appears to be a combination of modulation of the intestinal microbiota and anti-
inflammatory effects on the intestinal mucosa. These include a reduction in 
inflammatory cytokine production and improved barrier function. 
 
The hypothesis for the current work was that PF caused an increased rate of 
differentiation of enterocytes at physiological concentrations. This was tested using 
Caco-2 cell culture and murine enteroids as in vitro models of the intestine. 
 
When Caco-2 cells were treated with PF, it caused an increase in intestinal alkaline 
phosphatase (IAP) expression and activity, a marker of enterocyte differentiation. This 
was associated with a decrease in cell proliferation and viability. Murine enteroids 
dissociated after several hours of exposure to PF, possibly due to interference with 
Wnt signalling.  
 
It was hypothesised that the observed effect of PF on Caco-2 cells might be mediated 
via the vitamin D receptor (VDR). However, when the activity of this receptor was 
reduced through use of an inhibitor, no change in PF-induced IAP activity and/or 
decrease in proliferation was observed. This suggests that the VDR pathway is not the 
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Chapter 1. Introduction 
1.1 Crohn's disease 
Crohn's disease (CD) is an inflammatory bowel disease (IBD) that can involve the 
whole gastrointestinal tract [1]. An over-reactive immune response results in patchy 
inflammation, leading to an altered intestinal environment as well as reduced digestive 
and absorption ability [2]. Symptoms flare up and get better again in periods of 
remission but it is a lifelong disease. Several environmental factors such as diet and 
antibiotics have been linked to the development of CD [3-5], that may contribute to an 
altered microbiota, considered another risk factor [5]. Chronic colonisation with 
pathogenic bacteria [6], and host genes associated with endoplasmic reticulum stress, 
anti-microbial peptide (AMP) secretion and autophagy [5] are also implicated. Thus, an 
as yet unknown combination of genetically predisposed enterocytes and colonocytes, 
environmental factors and/or the presence of microbial dysbiosis (that may also 
include the presence of pathogenic bacteria) are likely to increase the risk of relapsing 
disease through mechanisms that include inflammation and/or bacterial invasion. 
 
1.2 Environmental factors 
The environmental factors that have been identified in case-control and cohort studies 
are varied, differ between cohorts of different ethnicities, and the mechanism(s) 
involved are poorly understood. Being a smoker, undergoing an appendectomy, and 
not being breastfeed as an infant are associated with an increased risk [4]. Dietary 
factors are also implicated, and may include consumption of emulsifiers that cause 
disruption of the protective mucus layer [5]. Bile acids are endogenous emulsifiers, but 
are normally completely reabsorbed in the ileum, preventing disruption of the 
protective mucus layer in the colon where there are much higher concentrations of 
bacteria and the consequences of thinner mucus would be greater [7]. The cells found 
at the surface of intestinal crypts are mainly absorptive cells which remove water and 
salt from the mucus, causing it to dehydrate and thicken so that it is more difficult for 
bacteria to move through, protecting goblet cells in the crypt where the mucus is less 
viscous in order for it to be more easily secreted [7]. Stress interferes with mucus 
production and control of viscosity, providing a potential contributing explanation as to 
why stress can cause worsening of symptoms in CD [7]. 
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There is also growing evidence that food additives such as maltodextrins, which are 
short glucose chains used to thicken food products, may increase expression of type 1 
pili in AIEC, increasing its ability to adhere to host epithelium and form biofilms [8]. The 
recent increase in CD, especially in more industrialised nations [9] is likely to be at 
least in part due to these and other food additives more commonly consumed as part 
of a highly processed diet, over-zealous or unnecessary anti-biotic use [10] and 
possibly environments that don't facilitate healthy immune tolerance [11]. 
1.3 Microbiota 
Reduced diversity within the gut microflora has been implicated in CD, as well as an 
overall reduction in bacterial abundance [5, 7, 12].  Significant changes to the 
representation of the major bacterial groups have also been reported, with a reduction 
in Firmicutes and Bacteroidetes, and an increase in mucosal adherent bacteria [5, 12]. 
  
CD patients reportedly have a greater proportion of Escherichia coli species within 
their gut microflora that include a subtype known as Adherent Invasive E. coli (AIEC) 
[13]. AIEC possess characteristic virulence factors that include expression of an 
altered type 1 pili FimH that enables bacterial adherence to the intestinal wall, resulting 
in upregulated expression of AIEC type 1 pili ligand CEACAM6 by the host cells [14]. 
Binding to CEACAM6 triggers AIEC internalisation by the enterocyte [15], and there is 
evidence that internalised bacteria can persist in susceptible individuals [16]. In 
addition, engagement of the CEACAM6 receptor by AIEC is associated with increased 
adherence of the enterocytes to the extracellular matrix (ECM). This prevents 
exfoliation, normally considered a process whereby infected cells are shed from the 
intestinal wall as an innate defence against infection [15].  
 
Adhesion of AIEC to human cell lines is not CEACAM-exclusive [17]. Furthermore, the 
type 1 pili used by AIEC to CEACAM6 are not unique to these bacteria. The E. coli 
subtype K-12 carries the same type 1 pili but is not invasive [18]. CEACAM6 mediated 
internalisation by host cells is a kind of endocytosis whereby the cell microvilli elongate 
to envelop the bacteria, powered by the movement of microfilaments and microtubules 
of the cytoskeleton [17]. From here AIEC can cause lysis of the endocytic vacuoles, 
allowing the bacteria to escape into the cell cytoplasm [17]. Once the cell is infected, 
AIEC causes disruption of tight junction complexes resulting in increased intestinal 
permeability [19]. This is a predictor of relapse in quiescent CD [20]. Once past the 
epithelial cell layer AIEC have the ability to survive and multiply in human macrophage 
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phagosomes, causing chronic tumour necrosis factor (TNF)-α secretion that further 
propagates the harmful immune response [16]. These characteristics make AIEC 
capable of driving chronic granulomatous inflammation, characteristic of CD lesions 
[1]. 
 
Patients with CD are also shown to have an increased immune reactivity to bacterial 
epitopes, including those of commensal bacteria, which may drive uncontrolled 
inflammatory reaction [5]. This may, in part, reflect the presence of specialised immune 
cells called microfold or M cells that sit between epithelial cells lining the intestine. The 
Peyer's patches of the ileum are especially concentrated with these cells and here 
there is also a reduced mucus barrier to facilitate exposure to non-invasive bacteria 
[6]. Normally, M cells help build tolerance of the epithelial cells to normal microflora 
antigens [6]. However, in patients with CD, this environment reportedly exacerbates 
bacterial biofilm formation on enterocytes in the ileum, contributing to this location 
being one of the most common sites of inflammation. 
1.4 Genetics 
Genome wide association studies have identified at least 71 gene loci that are 
associated with an increased risk of CD [21]. The three most strongly associated are 
autophagy related protein 16-like 1 (ATG16L1), immunity related GTPase family M 
(IGRM) and nucleotide oligomerization domain 2 (NOD2). ATG16L1 normally forms a 
protein complex that allows formation of autophagosomes that enable cells to degrade 
old or dysfunctional organelles, consume cellular components for energy in times of 
starvation, and are also important for killing intracellular pathogens [21]. The exact 
action of IGRM is not fully known, but is also thought to be involved in autophagy [21]. 
Mutated alleles of NOD2, that normally codes for an intracellular receptor for bacterial 
muramyl dipeptide prevents Paneth cells and immune cells from detecting and thus 
responding to infection as effectively [21]. NOD2 mutations are also associated with 
leakier intestinal epithelium, both in CD patients and 10-30% of their first degree 
relatives [22]. Another risk gene Xbp1 is involved in endoplasmic reticulum stress 
response and AMP secretion by Paneth cells, reducing the ability of the host cells to 
cope with the stress of infection, and further decreasing AMP secretion [5]. Patients 
with CD have been shown to secrete less AMPs even in times of remission [5]. The 
greater the number of at risk alleles, the higher the risk of developing disease via the 
creation of an environment in which bacteria can more easily pass through the 
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protective mucus and infect the host cells that, in turn, have a reduced ability to clear 
the infection [5]. 
1.5 Inflammation 
The symptoms of Crohn's disease are fuelled by recurring bouts of uncontrolled 
gastrointestinal inflammation. Patients with CD have been found to have an overactive 
immune response against even normal bacterial antigens, for which healthy individuals 
have a tolerance, suggesting that they have a pro-inflammatory predisposition [6]. 
TNF-α and other inflammatory mediators have been shown to promote inflammation in 
the gut and increase leakiness of the intestinal wall through increasing activity of 
myosin light chain kinase (MLCK), which causes disorganisation of tight junctions [6]. 
This allows luminal bacteria access to the gut mucosa where innate defences further 
promote inflammation [23]. The pathogenesis of CD has been linked to constitutive 
overproduction of TNF-α, produced by chronic activation of leukocytes, In addition to 
inflammation, TNF-α also increases apoptosis in differentiated intestinal cells, causing 
death of the cells that provide the best barrier to bacterial infection [7], evidenced by 
the therapeutic success of anti-TNF-α antibodies in patients with CD [23].  
 
 
1.6 Epithelial barrier function 
 
The lining of the gastrointestinal tract is exposed to anything that is ingested, having to 
simultaneously allow absorption of macro and micronutrients while preventing anything 
potentially harmful from entering the bloodstream [24]. In order to perform both these 
functions in the small intestine a wall of enterocytes carry enzymes, regulated 
transporter proteins and protein complexes that hold the cells together in a tight layer 
[25]. Tight junctions at the apical surface restrict the movement of water and solutes 
and are essential for barrier integrity [25]. Dysfunction can be caused by inflammation, 
with the consequence that bacteria and their by-products can more easily enter the 
mucosa and submucosa, and trigger further inflammation [22]. 
 
Enterocytes have a high rate of cell turnover. They are produced by stem cells in 
intestinal crypts and migrate up the villus over 4 to 8 days, and then are shed at the 
apex of the villus (Figure 1.1) [7, 12]. These stem cells also produce enteroendocrine 
cells which release hormones in response to luminal contents, goblet cells which 
produce the protective mucus layer, and Paneth cells that move down the crypt and 
protect the stem cells by releasing antimicrobial peptides (AMPs) [26]. 
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Figure 1.1: Small intestine cell differentiation and migration. Stem cells that reside in the 
crypt generate enterocytes, endocrine cells, and goblet cells that migrate up the villus where 
they die and are shed by anoikis. Paneth cells are also produced; these cells migrate to the 
base of the crypt where they protect the stem cells through the production of anti-microbial 
peptides. Sourced from [12]. 
 
In healthy individuals, bacteria are preventing from coming into contact with the 
intestinal wall by a layer of mucus [7] that, in addition to forming a barrier, also 
contains secreted IgA specific to bacterial epitopes that help to further restricting 
bacterial movement [6]. However, biopsies from patients with CD show a concentrated 
layer of bacteria growing directly beside the enterocytes, with some even surviving 
within the cells [7].  
 
Anti-microbial peptides (AMPs) are small proteins with broad anti-pathogen effects, 
and include defensins, cathelicidin, lysozyme, and phospholipase A2, all of which are 
produced in the small intestine primarily by Paneth cells. In addition, the enterocytes 
that form the gut barrier secrete alkaline phosphatase (ALP) [27, 28]. ALP is an 
enzyme thought to enact an antibacterial effect through dephosphorylation of pro-
inflammatory lipopolysaccharide [29]. However, evidence that ALP is produced in 
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increasing quantities as enterocytes differentiate has led to ALP secretion being used 
as a marker of enterocyte differentiation (that includes both transformed and primary 
cells) [28, 30, 31]. 
 
Reduced bacterial counts are typically seen in more inflamed regions of the intestine 
due to the migration of stimulated white blood cells into the mucus layer, but the 
bacteria that are taken up by cells can cause ongoing inflammation, potentially leading 
to ulcers and abscesses [7]. Interestingly, infected enterocytes are more often seen at 
the bottom of the intestinal crypts, where they are generated from a pool of stem cells. 
As these cells migrate from the crypt to the villous they develop a more robust 
phenotype as a result of differentiation, with fully differentiated cells reportedly less 
likely to be infected despite a much greater exposure to bacteria [7]. Thus cell 
differentiation appears to provide a more effective barrier to further bacterial invasion 
and inflammation. A well differentiated epithelium, the overlying layer of thick mucus 
and the anti-microbial peptides that it contains all help prevent the movement of 
infectious or toxic agents from entering the body. 
1.7 Vitamin D 
Active vitamin D, otherwise known as vitamin D3 and as 1,25, dihydoxycholecalciferol, 
is a hormone that plays an important role in regulating Ca2+ and PO43- absorption, 
storage and excretion, as well as immuno-modulatory effects [32]. It is estimated that 
around 3% of the human genome is regulated directly or indirectly by the vitamin D 
endocrine system [32]. Vitamin D is synthesised in vivo with exposure to ultraviolet-B 
radiation (UVB), which converts a cholesterol derivative to cholecalciferol that is 
released from the skin into the blood stream. Cholecalciferol is converted to the 
prohormone calcidiol in the liver, which is then transported in the blood by the Vitamin 
D Binding Protein. An enzyme found mainly in the kidneys called CYP27B1 (25-
hydroxyvitamin D3-1α-hydroxylase) converts the prohormone to the active form of 
vitamin D, calcitriol. However, evidence is emerging that this final step in this pathway 
can occur in other cell types that express this enzyme [33]. This includes monocytes, 
macrophages [34], enterocytes and colonocytes [35]. The vitamin D receptor (VDR) is 
a nuclear receptor that dimerises with the retinoid-X receptor in the presence of 
calcitriol, allowing it to bind to the hormone response elements that control over the 
expression of certain genes [30]. Accordingly, VDR mediates most of the known 
downstream effects of active vitamin D [33].  
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Recent evidence has found that long term vitamin D supplementation improves 
symptoms for people with CD [36]. The addition of vitamin D to an intestinal cell line 
causes resistance to the effects of TNF-α, with improvements in monolayer leakiness, 
tight junction organisation and reduction in inflammatory transcription factor Nuclear 
Factor (NF)-κB activation [20, 22, 32]. Vitamin D up-regulates expression of several 
tight junction proteins, including occludin, ZO-1, ZO-2, and vinculin [37]. Vitamin D has 
been shown to induce the expression of intestinal alkaline phosphatase (IAP) [30] and 
cathelicidin [34], two anti-microbial peptides that are also markers of enterocyte 
differentiation [38]. There is also evidence that activation of the Vitamin D receptor can 
affect the Wnt signalling pathway via decreased β-catenin and increased E-cadherin 
activity, resulting in decreased cell division and increased differentiation in cultured 
cells [37]. 
1.8 Butyrate 
Butyrate is a short chain fatty acid produced by bacteria in the colon from 
carbohydrates that cannot be broken down by digestive enzymes in the small intestine. 
Normally considered to provide an important energy source for colonocytes, there is 
growing evidence that butyrate, like Vitamin D, can affect host cellular pathways.  
 
Exposure to butyrate causes an increase in expression of a vitamin D activating 
enzyme [33] and is associated with a dose-dependent increase in IAP activity, CEA 
protein concentration and trans-epithelial electrical resistance (TEER) [39]. Butyrate is 
also shown to inhibit Caco-2 cells from moving into the DNA synthesis (S) phase of the 
cell cycle without increasing the rate of cell death, which appears to mimic 
spontaneous differentiation [39]. This butyrate-related effect of enhanced cell 
differentiation most likely helps maintain barrier integrity against inflammation-
perpetuating bacteria, and provide a possible indirect mechanism for the benefits of 
PF. Intriguingly, butyrate promotes cell differentiation and apoptosis in cancerous cells 
and cell lines while having the opposite effect in healthy colonocytes [30]. These 
differences may be explained by a much slower butyrate metabolism demonstrated in 
Caco-2 cells that may cause butyrate to accumulate within cells and elicit the toxic and 
pro-apoptotic effects at much lower concentrations [39]. Normal cells would also have 
the protection of a layer of mucus that would insulate the cells from a high luminal 
concentration [39]. Thus effects in cell lines derived from abnormal cells may differ 
from those seen in vivo but butyrate still provides an alternative stimulant and positive 
control for many markers of cell differentiation. 
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1.9 Enteral nutrition 
As CD can cause loss of appetite and severe malnourishment, and may be resistant to 
standard treatment, patients may be given exclusive enteral nutrition (EEN), a 
nutritionally complete liquid diet. EEN has been shown to have effects in the body 
beyond mere nutrition, especially when given exclusively over many weeks, and is just 
as effective as corticosteroids and infliximab at inducing remission [23], but without the 
side effects that can mean that they are contraindicated or intolerable. For infliximab 
these include increased susceptibility to common infections, risk of lymphoma and 
production of anti-infliximab antibodies that render the drug ineffective [9]. Long term 
use of corticosteroids commonly causes poor wound healing, central adiposity, loss of 
bone density, immunosuppression, as well as growth retardation in children [9]. Some 
antibiotics can cause short term improvement in CD, but they are not an effective long 
term treatment and have side effects as a consequence of their lack of specificity, 
affecting both harmful and helpful bacterial species [40].  
 
There are two main kinds of formulae that may be used for EEN: elemental and 
polymeric, which means that they are composed of predominantly simple sugars and 
amino acids, or whole carbohydrates and proteins, respectively. Polymeric formula 
(PF) is cheaper, more palatable, and is just as effective as elemental formula despite 
requiring additional digestion [41]. Accordingly, PF is increasingly being used to treat 
children and adults with CD.  
 
PF causes changes in the microflora, favouring Bacteroides species that have been 
associated with a reduction in inflammation [42]. PF inhibits the degradation of IκBα, 
resulting in decreased NF-κB activity, a transcription factor that promotes an 
inflammatory response and TNF-α production [43]. PF increases the expression of 
carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6, a marker of 
enterocyte differentiation [44] and prevents TNF-α induced tight junction dysfunction, 
IL-8 production, and increase in epithelial permeability at concentrations of 10% and 
20% which would be found in someone taking PF exclusively [23]. However the 
mechanism(s) behind its effectiveness in treating CD are not yet fully understood. 
 
Vitamin D is included in standard PF preparations in order to ensure that all vitamin 
recommended intakes are met enterally, even though most individuals get most of 
their vitamin D through skin exposure to UV radiation. Therefore in CD patients on long 
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term EEN, levels of intra-luminal vitamin D are likely to be much greater than would 
otherwise be present. 
1.10 Research aim 
The mechanism by which immunosuppressants treat IBD are relatively well 
understood. However, currently used dietary treatments contain a complex 
composition of potentially active agents, which makes it more difficult to elucidate how 
they afford protection. Polymeric formula has been shown to have many different 
effects on both enterocyte function and microbiota composition, but the underlying 
mechanism(s) for each of these has yet to be demonstrated. There is evidence that 
dietary components can affect the differentiation of the intestinal epithelium [30, 39]. 
Differentiation has been shown to improve barrier function, dysfunction of which is a 
characteristic of those who have, and those who are at increased risk of CD [19, 25]. 
 
The aim of this project was to investigate the effects of polymeric formula as used for 
EEN on the rate of intestinal epithelial cell differentiation, using two models of the small 
intestine. The models to be used include a continuous enterocyte cell line and three 
dimensional primary cell culture. The intention of this project is to increase 
understanding of how polymeric formula is effective at managing CD, in order to 
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Chapter 2. Materials and Methods 
2.1 Caco-2 cell culture 
Caco-2 monolayers were incubated in Dulbecco's DMEM (Gibco, Auckland, New 
Zealand) with 10% Fetal Bovine Serum (Gibco), 1% Penicillin-Streptomycin (Gibco) 
and 1% Non-Essential Amino Acids (Gibco) at 37°C under 5% CO2 in 75mL flasks. 
Passages 56-95 were used for all experiments. Cells were passaged weekly, with 
TrypLE Express (Gibco) used to lift the cells. Cell monolayers cultured for more than 7 
days had their medium changed every two or three days after the first week. For 
experiments, Caco-2 cells were cultured in twenty-four well plates with a well area of 
2cm2 (Nunc, Sigma-Aldrich, New Zealand) under 1mL of medium, or 12 well plates 
(Nunc, Sigma-Aldrich, Auckland, New Zealand) with an area of 4cm2 under 2mL of 
medium. Incubation time with TrypLE Express was increased from 10 to 20 minutes to 
reduce clumping of the cells, which was found to be an issue especially as cell density 
increased. Also, cells treated with PF required additional washes in PBS to remove as 
much residue as possible before TrypLE Express was added. This enabled cells to be 
lifted. 
2.2 Cell counting 
To count the cells, 20µL of cell suspension was diluted 1:1 in 0.5% (w/v) trypan blue 
(Sigma-Aldrich) in PBS, mixed and pipetted into a haemocytometer. The number of 
cells in the 16 square grids in each corner were counted, averaged, doubled (to take 
into account dilution in trypan blue) and multiplied by 104 to give the concentration of 
cells per ml of suspension. Non-viable cells are permeable to trypan blue dye and 
appear blue under the microscope, enabling estimation of viable versus non-viable cell 
numbers. 
2.3 Flow cytometry 
Caco-2 cells (5 x104 or 1 x 105) were cultured in twenty-four well plates for 3 to 7 days. 
The cells were washed twice with 0.5mL PBS, then incubated at 37°C for 10 minutes 
with 300µL TrypLE Express (Gibco). Three hundred microliters of medium was added 
to each well and the resultant cell suspension centrifuged at 800 x g for 3 minutes. The 
speed at which the cells were pelleted was initially 500 x g but this was increased to 
800 x g, as this did not affect cell viability while creating a tighter pellet that was less 
likely to fall apart when the supernatant was aspirated. After aspiration the cells were 
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re-suspended in 300µL medium. This was divided between two V-bottomed wells in a 
96 well plate (Nunc, Sigma-Aldrich) (130µL each), and then centrifuged at 295 x g for 
5 minutes. Both supernatants were aspirated and one pellet was re-suspended in 
50µL PBS, the other in 50µL Annexin Binding buffer (Invitrogen, Auckland, New 
Zealand). Five microlitres of propidium iodide (Invitrogen, Thermo Fisher Scientific, 
Auckland, New Zealand), and 2.5µL of Annexin V fluorescein conjugate (Life 
Technologies, Thermo Fisher, Auckland, New Zealand) was added to each sample, 
which were incubated at RT in darkness for 15 minutes. A further 150µL of either PBS 
or Annexin Binding buffer was added to the respective samples before reading by the 
cytometer. The PBS Annexin control was used to set the threshold for FITC auto-
fluorescence. The proportion of cells over this threshold were considered apoptotic or 
dead depending on whether they were PI negative or positive respectively. 
2.4 Intestinal alkaline phosphatase activity  
Intestinal alkaline phosphatase (IAP) activity was determined by measuring the change 
in absorbance as the colourless substrate para-nitrophenylphosphate (PNPP) was 
hydrolysed to form the yellow product para-nitrophenol (PNP) [45]. The substrate 
solution (2.5g/L PNPP (Sigma-Aldrich), 100mM diethanolamine, 150mM NaCl, 2mM 
MgCl2, pH 9.5) was aliquoted and stored at 20°C until required to reduce the rate of 
spontaneous decomposition. The collection buffer (0.1M Tris-HCl, 150mM NaCl, pH 
8.0) and was kept at 4°C. 
 
Caco-2 cells were washed once with 1mL PBS before the addition of 300µL of cold 
collection buffer to each well. The reverse end of a 200µL pipette tip was used to 
scrape the bottom of the well, with the resultant suspension of fragmented cells 
collected into a microfuge tube and mixed vigorously by pipetting to aid further 
dispersion. Fifty microliters of cell lysate was added to each of 2 microcentrifuge tubes, 
and 150µL of pNPP substrate solution was added to one of each after set time 
intervals. To the other microcentrifuge tube, 150µL of substrate solution not containing 
PNP, followed by 50µL of 0.5M NaOH was added as a blank for each sample. 
Samples were then repeatedly inverted to prevent the cells and cell fragments from 
settling out. After 8 minutes, 50µL 0.5M NaOH was added to the test samples to stop 
the reaction. The tubes were centrifuged for 3 min at 4,000 x g to pellet the cell debris. 
Two hundred microliters of supernatant was removed and added to separate wells in a 
96 well plate. Absorbance was read at 405nm using a Spectramax-190 platereader 
(Molecular Devices) and Softmax Pro V5.3 software (Molecular Devices). 
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The relationship between the concentration of para-nitrophenol (PNP) and its 
absorbance at 405nm at the same volume and pH as present in the enzyme assay 
was determined to allow the results to be converted from abstract absorbances to units 
of concentration. Multiple concentrations of the PNP product in the linear range of 
absorbance were averaged across three independent measurements and the gradient 
used to determine the constant (Figure 2.1). Dividing the absorbance by 0.028 gave 
the concentration of PNP product in µM.  
 













Figure 2.1 PNP concentration versus optical density. Optical densities at 405nm (OD405) 
were graphed against the concentration of PNP (uML), and the resultant standard curve used 
to enumerate IAP activity in samples by absorbance. The multiplication factor derived from the 
gradient was 0.028. Results shown are ± SEM of 7 independent experiments.  
 
All IAP measurements were performed on live cells as freezing was found to decrease 
activity (results not shown). All samples at each time point were exposed to the same 
substrate solution at the same temperature over the same period of time to allow 
comparison of IAP activity. To determine the amount of PNP in cell homogenates in 
µM, absorbances were multiplied by 3 (50µL from 150µL) and divided by 0.028, the 
value derived from the gradient of the graph (Figure 2.1). IAP activity in the cell culture 
supernatant was determined by multiplying absorbance by 20 (50µL from 1mL) and 
dividing by 0.028.  
 
Each assay included samples from duplicate wells. The volume of sample, PNPP 
substrate concentration, incubation time and temperature for the IAP assay were 
adjusted to ensure that the levels of IAP activity in the samples fell within the linear 
range of change in absorbance over time. Due to the opacity of the cell medium with 
the addition of 20% (v/v) PF cell medium, it was not possible to measure IAP activity in 
the supernatant of these samples. 
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2.5 Western Blotting 
Caco-2 cells (1 x 105) were grown in 24-well plates for 6 to 8 days (with and without 
the addition of 20% (v/v) PF at day 5). Media was removed and the cells were washed 
once with PBS before being lifted with TrypLE and pelleted, as described previously. 
The pellet was re-suspended in 100µL of RIPA buffer (50mM Tris-HCl pH 7.5, 150mM 
NaCl, 1% (v/v) NP-40, 1x protease inhibitor (Complete Mini; Roche, Basel, 
Switzerland), 2% SDS, 2% mercaptoethanol, 5% glycerol v/v, 0.01% (w/v) 
bromophenol blue), transferred to a microcentrifuge tube and kept on ice for 30 
minutes before centrifugation for 20 minutes at 30,000 x g. The resultant cell lysate 
pellet and supernatant were separated and frozen at -20°C.  
 
Protein concentration was initially measured using a Direct Detect Infared 
Spectrometer (Merck Millipore, New Zealand). However, residual PF in some cells 
lysates meant that cellular protein concentration could not be used to control for 
sample loading onto gels. Instead, a fixed volume of each sample that had been 
prepared the same way was used, with densitometric analysis of the IAP band 
compared to that of GAPDH (as a housekeeping gene) used to determine the relative 
difference of IAP expression between the different conditions.  
 
The samples were diluted 1:1 in PBS and then 4:1 with 5x sample lysis buffer (300mM 
Tris, 10% (w/v) SDS, 25% (v/v) glycerol, 0.05% (w/v) bromophenol blue, 1.6M β-
mercaptoethanol, pH 6.8) before being heated at 95°C for 10 minutes. A total of 15µL 
(sample and lysis buffer) was loaded onto a 12% polyacrylamide gel, with Precision 
Plus Protein Standards (Bio-Rad, Auckland, New Zealand) included on each gel as 
molecular weight markers. The gel was electrophoresed at 200V until the dye front 
reached the bottom of the gel (50-55 minutes). The separated proteins were then 
transferred to a polyvinylidene fluoride (PVDF) membrane (Hybond-P™, pore size 
0.45µm; GE Healthcare, Little Chalfont, UK) using a wet transfer method, whereby the 
polyacrylamide gel and PVDF were sandwiched between filter paper in cold transfer 
buffer (10% (v/v) methanol, 50mM Tris-base, 0.38M glycine) under 100V for 60 
minutes.  
 
The PVDF membrane was blocked in 5% (w/v) bovine serum albumin (BSA; AlbuMAX 
I Lipid rich BSA, Gibco) in Tris Buffered Saline with 0.05% Tween 20 (TBST) for one 
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hour at RT before being incubated overnight at 4oC in primary antibody. Mouse 
monoclonal anti-IAP (Abcam ab54776, Melbourne, Australia) and rabbit polyclonal 
anti-IAP (Abcam ab95462) were used at a concentration of 1:500, diluted in 2% (w/v) 
BSA (in TBST). The membrane was washed four times for 5 minutes in TBST before 
incubation with the secondary antibody in TBST for two hours at RT. Goat anti-mouse 
IgG antibody conjugated to horseradish peroxidase (HRP) (Pierce 31430, Thermo 
Fisher Scientific) was used at a concentration of 1:5000, also diluted in 2% (w/v) BSA 
in TBST. Goat anti-rabbit IgG HRP conjugated antibody (Abcam, ab97051) was used 
at a concentration of 1:2000. The membrane was washed four times for 10 minutes 
each in TBST before being drained and incubated for four minutes under ECL Plus 
Pierce Blotting Substrate (Thermo Fisher Scientific). Images were created using 
UVITEC Cambridge Gel Documentation system (UVITEC, Cambridge, UK). 
Densitometry using UVIband software (UVITEC) was used to quantify the relative 
amounts of proteins in the bands. 
2.6 Fluoresence microscopy 
Caco-2 cells (1 x 105) were grown on 16mm round coverslips that were ethanol-
sterilized before being placed in the bottom of each 4cm2 well (in a 12-well plate) in 
total volume of 2 mL media per well. The cells were allowed to settle and grow for 5 
days before the media was changed, with and without the addition of 20% (v/v) PF for 
up to 72 hours. The media was removed and the cells were fixed with the addition of 1 
mL 4% w/v paraformaldehyde (PFA) pH 7.4 for 45 minutes at room temperature. The 
PFA was aspirated and the coverslips stored in PBS at 4°C until needed. 
 
Before staining the cells, each coverslip was washed twice (total 20 minutes) in 2 mL 
1,4-piperazinediethanesulfonic acid (PIPES) buffer (60mM PIPES pH 6.8) before 
unbound sites were blocked with 500µL of 5% (w/v) BSA in PIPES buffer) for 45 
minutes at room temperature. Each coverslip was washed three times for five minutes 
in 2 mL PIPES buffer on a shaker. Enteroid cells were permeabilised with 500µL Triton 
solution (0.5% (v/v) Triton-X100 in PIPES buffer) for 15 minutes at room temperature 
before staining. Caco-2 monolayers were not permeabilised. After another two 5 
minutes washes each coverslip was incubated overnight at 4oC on a rocker in 500µL 
of primary antibody (diluted in 2.5% (w/v) BSA in PIPES buffer).  
 
Following four 5 minute washes in 2 mL PIPES buffer on a shaker, the membrane 
incubated in 500µL of FITC-conjugated secondary antibody (diluted in 2.5% (w/v) BSA 
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in PIPES buffer) for 2 hours at room temperature. 1:1000 Hoechst 33342 (Life 
Technologies; 10mg/L diluted in PBS) was added to each well for 20 minutes at room 
temperature to stain the nuclei. This was followed by four washes of 2 mL 0.05% (v/v) 
Tween-20 in PIPES buffer on the shaker, and a last wash for 10 minutes in PIPES 
buffer alone. The coverslips were removed from the wells and carefully touched to a 
paper towel to drain, then placed up-side-down on a slide with a drop of Antifade 
Mountant (0.1% w/v p-phenylenediamine, 50mM Tris-HCl pH 6.8). The slides were 
stored at 4°C in the dark until viewed under fluorescence microscopy. Images were 
taken using a Zeiss Axio Imager Z1 microscope (Auckland, New Zealand) with 
AxioVision software (Zeiss). 
2.7 Cell migration assay 
Half a centimetre was cut off the wider end of 200µL pipette tips, giving plastic collars 
that were then sterilised in 70% ethanol for 15 minutes. Excess ethanol was removed 
and each collar was placed (with the un-cut edge down) in the centre of a well (using a 
12 well plate). The plate was then carefully placed in a 37°C incubator with the lid 
propped up slightly for at least 15 minutes. This allowed the ethanol and most of the 
water to evaporate, and facilitated adherence of the rings to the surface of the well. 
Caco-2 cells (1 x 105) in approximately 70µL of media were added to the inside of the 
ring, followed by another 50µL of medium to remove cells adhering to the sides of the 
ring. This resulted in a confluent layer of cells on the bottom of the well inside the collar 
following incubation for 24 hours at 37°C. Importantly, there was no evidence of cells 
and/or medium outside the collar after this time.  
 
Medium with or without the addition of PF was added to the outside of the ring, which 
was removed leaving a circle of confluent cells centred in the middle of well. The cells 
were cultured for up to 18 days, at which timepoint untreated cells were shown to 
spread more than half the way to the edge of the well. A scalpel blade was used to 
mark the furthest point that the cells had reached in 2 dimensions, and then a ruler 
used to measure the distance to the nearest half-milimeter. From this distance, the 
initial diameter of 6mm was subtracted to give the change in length, and then the 
mean calculated for each treatment condition. 
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Figure 2.2: Cell migration assay. Wells on the left show the cell suspension trapped within 
the base of a pipette tip, whereas those on the right show the incubation phase where the 
medium has been added and the tips removed, allowing the cells to spread. 
 
2.8 Enteroids 
Juvenile male C57/BL6 mice were euthanized by neck dislocation. The small intestines 
were dissected out and flushed twice with ice cold PBS. The intestine was opened 
lengthwise and cut into 1cm pieces that were added to 5mM EDTA for 5 minutes on 
ice. The tissue was then transferred into cold PBS and shaken for 30 seconds, before 
being returned to the EDTA for another 5 minutes. This was repeated several times, 
with each fraction checked microscopically for quantity and proportion of villi and 
crypts.  
 
The crypt-rich fractions were put through a 70µm filter to enrich for crypts, which were 
then pelleted by centrifugation at 600 x g for 3 minutes. The pellet was resuspended in 
200µL of Matrigel Matrix (Corning, USA) that had been removed from the -20°C 
freezer and kept on ice. The resultant suspension was transferred to 12 or 24 well 
plates as a shallow bubble in the centre of the well. If intending to immuno-stain the 
enteroids, the Matrigel was laid down on sterile coverslips in the wells. 
 
The Matrigel was allowed to set (10 minutes at 37°C) before culture medium 
(Advanced DMEM (Gibco)) with growth factors (100ng/L Murine Noggin (PeproTech, 
USA), 500ng/L Human R-spondin (PeproTech, USA), 50ng/L EGF (PeproTech, USA), 
1mmol/L N-Acetyl-L-Cysteine (Sigma), 1x N2 (Gibco, USA), B27 (Gibco, USA) and 1x 
Penicillin-Streptomycin (Gibco) was added to just cover the top of the Matrigel [46, 47]. 
BMP antagonist Noggin, EGF and stem cell Wnt signalling agonist R-Spondin were 
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added again to the medium at the same concentration 48 hours later to promote 
growth and differentiation [47]. After two more days the existing medium was removed 
and new DMEM with fresh growth factors were added. This cycle of alternating full 
medium change and growth factor addition was repeated every two days over the 
course of the experiment. 
 
A modification of this mode; involved incubating the stem cell rich crypts on a layer of 
Cellmatrix Type I-A porcine tendon collagen (Component A; Nitta Gelatin Inc., Osaka, 
Japan) [48]. 
 
Approval was received from the University of Otago, Christchurch Animal Ethics 
Committee to retrieve bowel tissue from animals being euthanized for another 
approved research/teaching protocol (Protocol GC2/14).  
 
2.9 Statistical analysis  
Results are presented as the mean ± standard error of the mean (SEM) for 
independent experiments repeated at least three times. All statistical analysis was 
performed using GraphPad Prism version 6.00 (2012) (GraphPad Software 
Incorporated, La Jolla, CA, USA). A t-test was used to compare differences between 
two groups of data, whereas one-way or two-way ANOVA were used for analysis of 
multiple data sets. Tukey’s test for multiple comparisons was used to compare data 
between more than two groups.   
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Chapter 3. Results 
 
The transition of undifferentiated to differentiated epithelial cells is an important part of 
maintaining barrier function in the gut [39]. Differentiated enterocytes are less likely to 
become infected with invasive bacteria or become leaky to bacterial antigens in the 
presence of host inflammation [7, 23]. Thus an ability to increase the rate of epithelial 
cell differentiation was considered to be a potentially underappreciated benefit of PF 
treatment. In support of this hypothesis is evidence that treatment of cultured gut 
epithelial cell lines with PF is associated with increased expression of antimicrobial 
peptides [24], increased trans epithelial electrical resistance (as an marker of 
increased barrier function) [23], and increased expression of CEACAM6 (as a 
releasable decoy that limits bacterial adherence to the gut wall) [44]. 
 
The Caco-2 cell line was used as a model to investigate whether polymeric formula 
(PF) might promote renewal of the gut epithelium. Caco-2 cells were originally derived 
from a human colon adenocarcinoma but are widely used as a model of the human 
small intestine as the cells are easily grown in the laboratory and share many of the 
characteristics of enterocytes [49]. These include the formation of a tight monolayer 
that can restrict diffusion of solutes, development of a brush border of microvilli with 
functional digestive enzymes, and the production of anti-microbial peptides (AMPs) 
[39]. Osmolite (Abbot Nutrition, New Zealand), a standard polymeric formula, was 
added to Caco-2 cells and the rate of cell growth was compared to that of untreated 
cells. Twenty percent PF was used for these experiments as there is evidence to 
suggest that this is likely to be the intraluminal concentration that would be found in 
someone who was taking polymeric formula exclusively [23]. 
 
Intestinal alkaline phosphatase (IAP) is an AMP that is produced in increasing 
amounts as gut epithelial cells differentiate [24]. The IAP enzyme is expressed on the 
cell membrane before being released into the lumen where it dephosphorylates and 
inactivates the inflammatory bacterial lipopolysaccharide (LPS) [29]. IAP is commonly 
used as a marker of cell differentiation, and activity can be measured using a 
phosphatase enzyme assay [28, 30]. Accordingly, IAP expression and release were 
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The objectives for this chapter were to: 
1. Investigate baseline measurements of untreated cells to determine cell 
numbers and time points for the proposed experiments.  
2. To confirm the relationship between cell differentiation and IAP activity. 
3. To determine the effect that co-culture with 20% (v/v) PF has on the rate of cell 
growth and IAP activity. 
 
3.1 Cell density 
Caco-2 cells seeded at two densities (1 x 105 and 5 x 104) increased in cell number 
over 7 days of culture. Not unexpectedly, the higher concentration of cells at T0 
transitioned from a proliferative phase to reach a plateau of around 5x105 cells/well by 
day 5 whereas the lower initial seeding concentration of 5x104 cells/well required 6 
days to reach a similar plateau (Figure 3.1). At this point the cells had reached 
confluence, and the genes involved in cell proliferation were likely down regulated in 
response to contact inhibition as the result of cell-cell contact [50]. For both starting 
cell concentrations, there was a steady increase in cell number over time, and at all 
subsequent time points cell numbers were significantly higher than observed at day 3 
(P<0.0001). 
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Figure 3.1: Caco-2 cell numbers increase over time. Trypan blue was added to Caco-2 cells 
before counting by haemocytometer. Results are the mean ± SE of three independent 
experiments. Raw data were analysed by 2 way repeated measures ANOVA. No significant 
differences were detected between the two concentrations of cells at any specific time point.  
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3.2 Cell viability  
The percentage of non-viable cells (determined by uptake of trypan blue dye) did not 
show any clear trend over time (Figure 3.2A), a finding that was supported by flow 
cytometry of propidium iodide (PI) and annexin stained cells (Figure 3.2B). One 
difference noted between the two methods was that cell death rates were higher when 
cells seeded at the higher concentration were counted manually. Despite this slight 
difference, both methods indicated that the rate of cell death in untreated Caco-2 cells 
ranged from 5% to 10% over the course of the 7 day experiment. 
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Figure 3.2: Assessing cell death. The percentage of dead cells were assessed by (A) 
counting the number of trypan blue-stained cells and (B) flow cytometry of annexin and 
propidium iodide (PI)-labelled cells. Results are the mean ± SE of (A) five and (B) four 
independent experiments. Raw data were analysed by 2 way repeated measures ANOVA. No 
significant differences were detected between the two concentrations of cells at any specific 
time point. 
 
3.3 Intestinal alkaline phosphatase activity 
Cell membrane-bound IAP activity increased each day (Figure 3.3A). Some of the 
initial increase was considered attributable to an increase in cell number, but as cell 
number began to stabilise IAP activity continued to rise. No difference in IAP activity 
was observed between the two different seeding concentrations of Caco-2 cells, with 
the average activity at day 3 between 9 and 10 micromoles of PNP per well, and 
between 25 and 27 micromoles by day 7. Over time the increase in IAP activity was 
significant (P=0.005) with both cell concentrations.  
 
IAP activity in the cell supernatant also increased over the 7 days (P=0.04; Figure 
3.3B), irrespective of cell seeding concentration. At day 3, an average of 64 
micromoles of IAP was detected in the wells seeded with the higher concentration of 
cell (1 x 105), whereas cells seeded at the lower concentration (5 x 104) produced 77 
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micromoles per well. By day 7, levels of IAP activity had increased to 89 and 100 
micromoles, respectively.  
 
The rate of increase in IAP was greater in the cell supernatant than in the cell 
homogenates, which supports the hypothesis that IAP is secreted by the cell [29].  
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Figure 3.3: Intestinal Alkaline Phosphate (IAP) activity. IAP activity was measured in (A) 
Caco-2 cell homogenate and (B) supernatant recovered following cell culture. Results are the 
mean ± SE of thee independent experiments. Raw data were analysed by 2 way repeated 
measures ANOVA. No significant differences in IAP activity were detected between the two 
concentrations of cells at any specific time point. 
 
3.4 Polymeric formula causes a decrease in cell 
number 
The addition of 20% (v/v) PF to Caco-2 cells at day 5 of culture was found to have a 
marked effect on cell number over time (Figure 3.4). Untreated cells continued to 
proliferate over time and numbers were significantly increased at 72 hours (P<0.01). In 
contrast, there was no significant increase in cell numbers in the PF-treated wells. 
Consequently, cell numbers were significantly higher in control wells at 48 and 72 
hours.  
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Figure 3.4: Cell proliferation slows with the addition of polymeric formula. PF (20%) was 
added to day 5 cultures of Caco-2 cells, and cell numbers were counted over 72 hours. Results 
are the mean ± SE of eight independent experiments. Raw data were analysed by 2 way 
repeated measures ANOVA. Asterisks indicate a significant difference between the two cell 
treatments at fixed times. ***, ****; P<0.001 and 0.0001, respectively.  
 
 
3.5 Polymeric formula is associated with loss of cell 
viability 
The difference in Caco-2 cell density following treatment with 20% PF must be due to 
either a decrease in cell proliferation and/or an increase in rates of cell death. To 
explore this further, the rate of cell death in the same samples was monitored by 
determining the number of non-viable cells (assessed by trypan blue staining). The 
results of these experiments showed that cell death in the untreated cells ranged from 
6% to 8% and did not increase over time. However, as shown in Figure 3.5, treatment 
of the cells with 20% PF caused a significant increase in cell death over time (P<0.05). 
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Figure 3.5: Non-viable cells increase following exposure to polymeric formula. Caco-2 
cell viability was assessed by counting of trypan blue stained Caco-2 cells, with and without 
exposure to PF. Results are the mean ± SE of eight independent experiments. Raw data were 
analysed by 2 way repeated measures ANOVA. Asterisks indicate a significant difference 
between the two cell treatments at fixed times. ***, ****; P<0.001 and 0.0001, respectively. 
 
 
3.6 Polymeric formula increases rates of apoptosis 
The increased number of trypan blue-stained Caco-2 cells following exposure to PF 
indicated a higher rate of cell death. This could be due to accelerated differentiation 
resulting in apoptosis at of the cells at the villus tips. Conversely if the cells were dying 
by necrosis, this would indicate a toxic effect of PF. In order to investigate this, day 5 
monolayers of Caco-2 cells treated with PF, or left untreated, were followed over time 
using live cell microscopy to track changes in the cell populations. Magic Red 
(Immunochemistry Technologies, USA) is a reagent that can move in and out of cells 
freely but becomes fluorescent in the presence of activated caspases, causing 
apoptotic but not necrotic cells to fluoresce red. Images were taken every five minutes 
over 10 hours, and a minimal volume of medium was added (400µL) to give a clearer 
image.  
 
Untreated Caco-2 cells showed a more rapid initial increase in caspase activity than 
PF treated cells. But after 8 hours, cells 20% PF treatment showed higher caspase 
activity and more diffuse pattern of fluorescence (Figure 3.6). However, it was unclear 
whether the observed PF-related effect was real, or a result of increased light 
scattering through the PF. Accordingly, it remains to be determined if the increased 
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Figure 3.6: Caspase activation in Caco-2 cells. Cell monolayers (untreated or treated with 
20% (v/v) PF were stained with Magic red as a marker of apoptosis. Two hourly images are 
shown, and all images had the same length of exposure. These images are representative of 
two independent experiments. 
 
 
3.7 Polymeric formula is associated with increasing 
IAP activity 
The next step was to determine if the observation that the effect of 20% PF upon cell 
growth was associated with any significant change in the IAP activity over the same 
period of time. The results of these experiments (Figure 3.7) showed that IAP activity 
in the untreated cells did not increase over time. However, treatment of the cells with 
20% PF caused a significant increase in IAP activity over time (P<0.0001). 
Consequently, IAP expression was significantly higher in PF-treated compared to 
untreated wells at 48 and 72 hours.  
 
























Figure 3.7: PF treatment increases cellular membrane associated IAP. Caco-2 cells were 
incubated with 20% (v/v) PF for up to 3 days, with IAP activity in the cell homogenates 
measured at 24 h intervals. Results are the mean ± SE of three independent experiments. Raw 
data were analysed by 2 way repeated measures ANOVA. Asterisks indicate a significant 




	   26	  
3.8 Polymeric formula increases membrane expression 
of IAP 
Five day old Caco-2 cell monolayers incubated with 20% (v/v) PF for 48 and 72 hours 
were then lifted and the cells lysed in RIPA buffer. The proteins were separated by 
electrophoresis before being transferred to PVDF membrane and probed with 
monoclonal antibodies against IAP. Each blot was then reprobed with an antibody 
specific for GAPDH. UVIband software (UVITEC) was used to analyse each band 
volume by densitometry and thus the density of IAP staining was determined relative 
to the staining intensity of GAPDH in the same sample.  
 
PF treatment was observed to increase cell-associated IAP staining at both time points 
(1.361 ± 0.487 and 1.901 ± 0.509 at 48 and 72 hours, respectively) when compared to 
untreated controls (0.710 ± 0.111). However, analysis of the raw data from three 




Figure 3.8: PF causes an increase in IAP protein expression. Cells incubated with 20% 
(v/v) PF for 48 and 72 hours were lysed in RIPA buffer and probed for antibodies specific for 
IAP. The blot was then reprobed with an anti-GAPDH antibody. Images are representative of 3 
independent experiments.  
 
Caco-2 cells grown on coverslips for 5 days were given fresh medium with increasing 
concentrations (0, 5, 10 and 20%) of PF for up to 72 hours. The cell monolayers were 
then fixed in 4% paraformaldehyde before being incubated with a monoclonal antibody 
against IAP. The cells were not permeabilised, enabling detection of IAP on the cell 
surface only. Binding of the primary antibody was subsequently detected using a FITC-
conjugated secondary antibody, while the cell nuclei were stained with Hoechst. All 
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exposure time of 500ms. There was no detectable fluorescence on slides without the 
primary antibody at 500ms of exposure (not shown). 
 
A marked difference in IAP protein expression between untreated and PF-treated cells 
was observed, as was a concentration-dependent effect of PF. In untreated Caco-2 
cells, membrane-associated IAP expression was seen to be discrete and not evenly 
distributed. With each increase in PF concentration, the IAP staining became more 
widespread and diffuse. A similar effect was observed when fluorescence microscopy 
was used to monitor Magic Red staining of PF-treated cells. Collectively, these results 
suggest that PF may be responsible for increased scattering of light, but it was clear 
that higher PF concentrations caused an increase in IAP fluorescence, which is 




Figure 3.9. Polymeric formula increases membrane-associated IAP. Caco-2 cells were (A) 
untreated, or treated with (B) 5%, (C) 10% of (D) 20% PF for 72 hours before being stained for 
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3.9 Polymeric formula causes a decrease in Caco-2 cell 
migration 
Increased levels of PNP in treated Caco-2 cells supports the hypothesis that PF-
treatment of gut epithelial cells may increase cell differentiation, contributing to the 
formation of a monolayer of cells that is maintained by cell-to-cell junctions [23]. To 
explore this idea further, Caco-2 cells were grown in a confined area for 24 hours, 
resulting in a circular monolayer of cells that was then grown for another 18 days with 
and without exposure to 20% (v/v) PF. 
 
Previous studies have performed migration experiments using commercial kits or by 
cutting through the cells with crude instruments such as razor blades [51]. This 
approach was tried but was found to be ineffective as the Caco-2 cell monolayers were 
so tightly adherent to each other that cutting resulted in the cells lifting from the plates 
(data not shown). Accordingly, another method was developed to assess the effect of 
PF treatment on cell migration. Using the base of a pipette tip, a suspension of 1x105 
cells were trapped within the circular area. After 24 hours the collar was lifted and the 
cells were incubated in medium with/without the addition of PF for 18 days (when 
untreated cells were noted to be approaching the edge of the well). The diameter of 
the monolayer was measured to the nearest half millimetre. 
 
Results showed that exposure to 20% PF reduced cell migration by 44% (Figure 3.10). 
In the time it took untreated cells to spread an average of 5.9mm, PF treated cells had 























Figure 3.10: PF decreases the rate of Caco-2 cell migration. Caco-2 cells grown to 
confluence in a restricted space were slower to grow beyond this area when exposed to 20% 
PF for 18 days. Results are the mean ± SE of four independent experiments. **; P < 0.01 (by t-
test). 
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3.10 Discussion 
 
The first objective of this chapter was to measure the rate of Caco-2 cell proliferation 
and differentiation so that an appropriate time point could be chosen for further 
experiments. Cell numbers were seen to increase between days three and five, 
gradually transitioning from a proliferative to a slower rate of growth indicative of 
differentiation from day five onwards. Despite the observed changes in the rate of cell 
proliferation, cell death remained relatively constant as reported elsewhere [30, 33, 
39]. Cell death varied between 5% and 10% for both concentrations when measured 
using trypan blue exclusion and flow cytometry. Cell viability did not appear to increase 
or decrease over time. 
 
These results, which suggested that the cells were confluent but only partially 
differentiated informed the choice of using cells grown for five days in a 24 well plate 
cells as the time point to add PF. This is a similar time frame to that found in vivo as it 
reportedly takes between four to eight days for new enterocytes to move from the base 
of the crypt to the top of the villi [7]. Choosing partially differentiated cells at day five 
enabled relative increases and decreases in differentiation to be distinguished. These 
differences were to be measured at 24, 48 and 72 hour time points. Both seeding 
concentrations resulted in predictable rates of cell division and death, and a similar 
level of IAP activity. A concentration of 1 x 105 was chosen with an intervention time 
point of five days as this is when proliferation slows down, which suggests the cells are 
beginning to differentiate. 
 
The next objective was to confirm that the cells were indeed beginning to differentiate 
as cell proliferation slowed. IAP levels, which are considered a marker of epithelial cell 
differentiation [28, 30], were quantified using paranitrophenol phosphate, a colourless 
substrate that becomes the yellow para-nitrophenol when acted upon by a 
phosphatase. Both membrane-associated and secreted IAP activity increased over 
time, indicating progressive differentiation, with no obvious difference relating to cell 
seeding concentrations. IAP activity in the cell supernatant was four times greater than 
membrane associated activity however activity in the supernatant was more difficult to 
detect due to the greater volume. This is consistent with an in vivo role for IAP as a 
secreted antimicrobial peptide, defending the epithelium against attack by adherent 
and/or invasive bacteria [29]. 
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Polymeric formula was found to have a significant effect on Caco-2 cell proliferation 
and differentiation. Cell numbers decreased over time in the presence of PF, resulting 
in 50% less cells after 72 hours. This decrease in cell number was associated with an 
increase in cell death, which was three fold greater than that observed in untreated 
cells. Live fluorescence microscopy of caspase activity was used to explore the 
hypothesis that PF-treated cells were undergoing accelerated differentiation rather 
than toxin induced necrosis. After 10 hours of PF, there was a significant increase in 
caspase fluorescence consistent with an increased rate of differentiation. This is 
supported by a marked increase in IAP protein expression and enzyme activity in the 
PF-treated cells, given that IAP is widely considered a marker of epithelial cell 
differentiation [28, 30]. However, with both methods of fluorescnce microscopy the 
signal was more diffuse in the PF-treated cells. This is likely to be due to increased 
light scattering from PF components that resist being washed off the cells. 
 
PF was also shown to cause a 44% decrease in cell migration. This can be attibutable 
to a decrease in cell proliferation and an increase in cell death as Caco-2 cells 
appeared to spread mainly through cell division. This is in constrast with results that 
have shown PF to support mucosal healing in vivo [9] and highlights one of the 
potential pitfalls of this in vitro reductionist model. 
  
With the Caco-2 cell model established, and evidence to suggest that polymeric 
formula has a measureable effect on cell growth and differentiation, the next step was 
to investigate whether PF had a similar effect on a more biologically relevant model of 
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Chapter 4 
 
The Caco-2 cell line is widely used to model the intestinal wall. Originally sourced from 
an adenocarcinoma of the colon [49], this cell line has been propagated in the 
laboratory for decades, with the cancer-causing mutations that the cells harbour 
retained and exacerbated by an in vitro environment that favours further anti-apoptotic 
and pro-survival change. Accordingly, using a cultured epithelial cell line such as 
Caco-2 cells may not accurately reflect how polymeric formula (PF) might act in vivo. 
 
Intestinal epithelial cells originate from stem cells at the base of the crypts between 
villi. Enterocytes migrate over 4 to 8 days to the top of the villi where they are shed into 
the intestinal lumen [7]. The stem cells also produce goblet, enteroendocrine and 
Paneth cells which produce intestinal mucus, hormones and anti-microbial agents, 
respectively [26]. Each cell type is polarised, with different functions at the apical and 
basolateral surfaces. Collectively, the complexity of these cell types that comprise the 
intestinal epithelium challenges the generalisability of using monoclonal cell lines to 
study the gut. 
 
In a favourable environment, the stem cell populations produce miniature intestinal 
epithelial structures that can easily used for controlled experimentation. These 
“enteroids” are an alternative cell culture model that more closely reflect the small 
intestine in situ as they contain many different cell types and are sourced directly from 
normal intestinal epithelium. The small intestine is removed from a mouse (or a biopsy 
collected from a patient during colonoscopy), with ion chelation and physical agitation 
used to remove crypts and villi from the submucosa. The villi are filtered out and the 
stem cell rich crypts are resuspended in an extracellular matrix (Matrigel) with the 
appropriate nutrients and growth factors. 
 
This is important because in vivo these nutrients would be readily available through the 
local blood supply and/or directly from the intestinal lumen. For example, stem growth 
factors are derived from myofibroblasts beneath the basement membrane [46]. One of 
the most important of these is Wnt, which is present in low concentrations at the tips of 
villi and high concentrations in the cypts in order to prevent the stem cells from 
differentiating. The Wnt signalling cascade is enhanced by the addition of Noggin and 
R-spondin [47]. Epidermal growth factor (EGF) would normally be supplied to cells 
through the blood supply and the addition of this to the enteroid media has been 
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shown to increase stem cell proliferation, increasing the size of enteroids [47]. In 
addition, cells that are stripped from their extracellular matrix (ECM) are susceptible to 
apoptosis in order to prevent abnormal cell growth. To overcome this, enteroids are 
suspended in Matrigel. This contains collagen IV and laminin, thus mimicking the 
stroma surrounding intestinal crypts, and helps the cells that form the enteroids to 
survive outside their body of origin. 
 
The objectives for this chapter were to: 
1. Develop mouse enteroids as a more biologically relevant model of the small 
intestine  
2. Investigate the effects of polymeric formula on murine enteroids 
 
 
4.1 Culturing murine enteroids 
Crypt cells isolated from the small intestine of a mouse were observed to close off into 
cysts by day 1 that continued to get larger as the stem cells continued dividing (Figure 
4.1). By day 4 new crypts were seen projecting from the inner mass of cells, and at 
day 7, the most successful enteroids had multiple crypts extending from the central 
lumen At this point parts of the enteroid were sometimes obscured by loose clusters of 
cells generated within the enteroid. 
 
It was observed that only some of the many crypts isolated from each mouse went 
onto to develop into large enteroid structures. Paneth cells within these structures 
were identified as darker cells at the base of the crypts, due to the high density of 
secretory granules they contain. The goblet cells were identified by their bulbous 
shape and their position intercalated between the enterocytes. It was also noted that a 
failure to consistently replenish the growth factors required for enteroid growth caused 
the structures to disintegrate into clumps of non-polarised cells (not shown). 
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Figure 4.1: Early and late mouse small intestine epithelial cell fractions. The first fractions 
are rich in villi (A) while later fractions are crypt rich (B) and contain the stem cell populations 













Figure 4.2: Development of enteroids over ten days. Mouse small intestine crypts were 
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Figure 4.3: Mouse small intestine enteroids at day ten. These images are representative of 
enteroids with multiple crypts showing new crypt formation. Magnification 10x. 
 
4.2 Enteroid response to PF 
After 10 days in culture the growth rate of the enteroids was observed to slow with few 
new crypts being formed. At this point, fresh medium was added to the enteroids, with 
and without the addition of PF. In a matter of hours the crypt and lumen structure of 
the PF-treated enteroids became less defined before fully disintegrating, appearing 
more like aggregates of cells rather than enclosed monolayers with a visible lumen 
and crypts projecting outwards. The enteroids that were not exposed to PF did not 
show such changes (Figure 4.4). 
 

















Figure 4.4: Effect on polymeric formula (PF) on enteroid morphology. Ten day old 
enteroids were treated with 20% (v/v) PF for 6 hours. Images were taken at each hour interval 
and for each treatment condition, of which 4 representative images were chosen. Magnification 
20x. This is representative of 2 independent experiments. 
 
Images taken at a lower magnification (Figure 4.5) clearly demonstrate the global loss 
of cellular structures with PF treatment. As a result the cells more closely resembled 
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the loose clumps of cells surrounding enteroids. In contrast, the untreated enteroids 
retained their structure, with goblet and Paneth cells identifiable in the crypts. This loss 
of enteroid structure does not appear to be a beneficial effect of PF. 
 




Figure 4.5: Changes to enteroid morphology after 6 hours of 20% PF treatment. Gross 
changes in enteroid appearance with 20% (v/v) PF treatment could easily be identified (right) 
when compared to untreated enteroids (left). Magnification 4x. 
 
Enteroids exposed to PF for 6 hours were fixed in paraformaldehyde and 
immunostained for evidence of IAP expression using a rabbit anti-IAP polyclonal 
antibody. Untreated enteroids incubated for the same period of time were also 
immunstained. Confocal microscopy revealed that the untreated enteroids contained 
IAP and that staining was more concentrated on the cell membrane (Figure 4.6). 
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Figure 4.6: IAP staining (yellow) of untreated ten day old enteroids. The enteroids were 
fixed in 4% paraformaldehyde (PFA) before being stained for IAP protein expression (yellow). 
Images shown are representative of untreated multiple crypt enteroid stuctures, with Hoescht 
used as a nuclear stain (blue). Scale bars 25µm. 
 
 
It was difficult to find remaining enteroid-like structures among the cells following 
treatment with PF; any that were present were small and had a pattern of staining that 
was more similar to the isolated cells that exist around the enteroids. The length of 
exposure was not kept constant between slides so a comparison of IAP protein 
concentration could not be made, only observations of the distribution of the protein. 
Rather than the more the diffuse cellular staining of IAP in enteroids that hadn't been 
treated with PF, a more granular pattern of staining was observed in the PF-treated 
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any enteroid features. The pattern of staining and cell behaviour appeared to mimic 




Figure 4.7: IAP staining (yellow) of 10 day old enteroids treated with PF for 6 hours. 
Images shown are representative of enteroids treated with PF for 6 hours before being fixed in 
4% paraformaldehyde (PFA) and stained for IAP protein expression (yellow), with Hoescht 
used as a nuclear stain (blue).Image (A)shows a typical aggregate of cells following enteroid 
treatment with PF, whereas (B) shows the only cystic structure remaining. Scale bars 25µm. 
 
One of the issues with this model is that the basolateral surface of the cells are 
exposed to the PF, whereas in vivo it is only the apical surface that would come in 
direct contact. Because of this, an attempt was made to overlay the newly isolated 
crypts on top of a collagen matrix instead of dispersing them within matrigel. With the 
same growth factors and nutrients present, the stem cells should have proliferated and 
produced a monolayer of intestinal epithelium, complete with multiple cell types and 
mucus production. However, the cells did not adapt readily to this environment and, 
accordingly, did not form monolayers on the collagen, even in the presence of 
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Figure 4.8: Day seven mouse small intestinal crypts grown on collagen surface. The 
method is identical to that used to grow Matrigel enteroids, with the exception that the crypts 
are instead layered on top of collagen as a two dimensional primary cell monolayer. These 
images, which were taken at day 7 and are representative of one experiment, show that stem 




The first objective of this chapter was to develop a method to culture enteroids as a 
model for studying the intestine. Crypts were isolated from murine small intestine as 
these were more readily available than human biopsies, and also produce a higher 
yield. The enteroids were sustained for up to three weeks but it was found that 
proliferation decreased after the first ten days. At this point the enteroids had reached 
0.2 - 0.3mm in diameter and had multiple crypts extending out from the central lumen. 
The presence of Paneth cells and goblet cells could be seen by live microscopy. 
These and other cell types have been identified in enteroids by the presence of villin 
on enterocytes, Mucin-2 within Goblet cells, lysozyme release by Paneth cells and 
Chromogranin A by enteroendocrine cells [26]. 
 
Ten days was chosen as the timepoint for the second objective, to investigate the 
effect that 20% (v/v) PF has on murine enteroids. The intention was to replicate the 
experiments undertaken using Caco-2 cells and measure the cellular response over 72 
hours. However, the 10 day old enteroid structures disintegrated within six hours of PF 
being present in the cell medium. The treated enteroids were stained for IAP, and 
although relative amounts of expression could not be determined, patterns of 
expression had drastically changed. Furthermore, almost all the crypts and enterocyte 
walls had dissociated. The change was relatively rapid compared to the effect the 
same concentration of PF had on Caco-2 cells, which took between one and two days 
to be markedly different from untreated cells.  
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The mechanism underlying the rapid disintegration of PF-treated enteroids remains to 
be investigated but it appeared to mimic what happened when the growth factors 
essential for enteroid growth and survival were depleted (not shown). This leads to the 
hypothesis that the PF may be binding to and/or competing with one of the growth 
factors that are essential for enteroid growth. If so, PF is likely to be interfering with the 
Wnt signalling pathway, which drives stem cell proliferation and movement of transit 
amplifying cells up the crypt. As the enterocytes move up the villus, Wnt 
concentrations decrease and bone morphogenic protein (BMP) concentrations 
increase, the cells stop proliferating and instead begin to differentiate [52]. PF has 
been shown to delay degradation of IκBα, which prevents NF-κB from migrating to the 
cell nucleus, causing anti-inflammatory effects [43]. Increased NF-κB activity has been 
associated with increased Wnt signalling in mouse enteroids [53]. Therefore reduced 
NF-κB activity due to PF treatment may inhibit this crucial pro-proliferation and de-
differentiation pathway. This most likely explains the observed pro-differentiation 
effects in both Caco-2 cells and primary enterocytes. However, it is apparent that 
cultured enteroids are considerably less robust than transformed cells, again 
supporting the hypothesis that components of PF may perturb the enhanced growth 
requirements of the enteroids. 
 
An alternative method that involved the culture of a primary enterocyte monolayer on 
collagen was investigated as a means to explore the effect of PF treatment [46, 54]. 
This method has many of the advantages of closed enteroids such as a self-
regenerating population of multiple non-transformed cell types but it also enables 
stimuli to be easily added to the apical or luminal surface and was considered to 
potentially provide a better model for imitating dietary interventions such as PF. 
However, the “flat” enteroids did not form the complex secondary structures such as 
crypts and tight monolayers seen in the matrigel enteroids under similar conditions. 
There was not sufficient time to determine the cause. 
 
The failure of the Matrigel enteroid model to evaluate the effects of PF is currently 
under investigation. The first goal will be to determine a dose response relationship of 
enteroids to PF, with the ultimate goal being repeating these experiments with 
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Chapter 5. Results 
 
Polymeric formula has a demonstrable effect on cell differentiation (Chapter 3) but the 
components responsible for this effect are currently not known. One promising 
candidate is calcitriol or active vitamin D, which is listed as an ingredient of Osmolite 1 
Cal (Abbott Nutrition), the polymeric formula used for this research.  
 
Vitamin D deficiency is commonly seen in IBD [51, 55-56], and VDR knockout mice 
have a significant reduction in the ATG16L1 protein, one of the main risk genes for CD 
[56]. Most individuals get almost their entire required daily intake through a reaction 
between UV and vitamin D precursors in the skin [32]. However, enteral nutrition 
formulas have to provide the recommended amounts of vitamins and minerals under 
the assumption that there is no other source. Therefore a relatively high amount of 
active vitamin D is consumed by patients taking enteral nutrition exclusively.  
 
Almost all known actions of vitamin D are mediated through the VDR [33, 56]. Caco-2 
cells, like normal enterocytes, have a functional VDR at all stages of differentiation 
[30]. Therefore if PF is acting through the VDR in normal cells, then it is likely that the 
effects on Caco-2 cells would be mediated through the same pathway. Like PF, 
vitamin D is known to inhibit activity of NF-κB [57], which has been shown to affect the 
Wnt pathway [32, 53]. Wnt and downstream signalling is important for regulation of 
cellular proliferation and differentiation [53] and therefore the vitamin D present in PF 
could potentially be mediating its pro-differentiation effects. 
 
Butyrate also reportedly signals through the VDR [33], resulting in a dose-dependent 
increase in IAP activity, CEA protein concentration and trans-epithelial electrical 
resistance (TEER) [39]. Butyrate also appears to drive crypt-to-villous differentiation in 
these cells [39]. 
 
It was hypothesised that the observed PF-related effects on cell differentiation were 
being mediated through the VDR. To investigate this, a vitamin D receptor inhibitor 
(VDRI) was obtained from the Teijin Institute in Japan. This VDRI (TEI-9647) has been 
shown to antagonise the VDR in human osteoclasts and monocytes [58-60]. However, 
there is no evidence to date regarding the ability of TEI-9647 to inhibit the VDR in 
Caco-2 cells. Butyrate and vitamin D were used as controls for these experiments. 
	   42	  
Both are shown mediate an increase in Caco-2 differentiation through the VDR [33] 
and to increase its expression [56] with butyrate shown to be more potent [33]. 
 
The objectives for this chapter were to: 
1. Measure IAP activity in Caco-2 cells exposed to vitamin D or butyrate.  
2. Evaluate the effectiveness of a vitamin D receptor inhibitor to reduce IAP 
activity in vitamin D and/or butyrate-treated Caco-2 cells, and to determine the 
extent to which the effect of PF is mediated through the vitamin D receptor. 
 
 
5.1 Butyrate causes a marked increase in IAP activity. 
IAP levels were measured in butyrate and vitamin D-exposed Caco-2 cells as a first 
step to determining their potential as controls to confirm the effectiveness of the VDR 
inhibitor in this cell line. Increasing concentrations of butyrate and Vitamin D were 
added to 5 day old Caco-2 cell monolayers for 72 hours, with IAP activity measured as 
a marker of cellular response. Vitamin D was added at concentrations of 20nM, 40nM 
and 80nM, which are similar to the concentration present in 20% (v/v) PF, and also 
within the range of concentrations reportedly used in other studies to activate the 
vitamin D receptor in cultured cell lines [51].  
 
Butyrate is known to cause an increase in the rate of differentiation at concentrations 
of 1mM to 2mM [38, 39]. This effect increases with dose but beyond 4mM butyrate 
becomes toxic to the cells and rates of cell death increase accordingly [38, 39]. 
Luminal butyrate produced by intestinal bacteria can reach 20mM but the protective 
mucus layer also reduces concentrations that reach the epithelium [39]. Butyrate was 
tested at 2mM, 4mM and 8mM, in order to observe the range of effects that butyrate is 
known to have.  
 
Vitamin D and butyrate increased IAP activity at all concentrations tested (Figure 5.1). 
Vitamin D had the least effect, and it was not significantly different from that measured 
in untreated controls. In contrast, butyrate had a significant dose-dependent effect on 
IAP activity (P<0.05). Furthermore, the highest concentration of butyrate tested (8mM) 
induced the cell to produce 3.4µM of PNP per million cells, which was significantly 
higher than the 1.3µM PNP per million cells produced in response to 20% (v/v) PF 
(P<0.05). 
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Figure 5.1: Dose-dependent effect of vitamin D and sodium butyrate on IAP activity. 
Caco-2 cells were exposed for 72 hours and activity was measured in the cell lysate. 20% (v/v) 
polymeric formula was used as a positive control. Results are ± SEM of 3 independent 
experiments. Raw data were analysed by repeated measure ANOVA, and asterisks linked by 
bars indicate significant differences between groups. *, P<0.05. 
 
 
5.2 High concentrations of butyrate causes Caco-2 cell 
death 
These results showed butyrate to be a more potent stimulator of IAP activity than 
vitamin D and therefore a more suitable control for evaluating the effectiveness of the 
VDRI in Caco-2 cells. However, there is evidence to suggest that 8mM butyrate may 
be cytotoxic [38, 39], which meant it was important to determine the optimal 
concentration to induce IAP expression with minimal cell death. 
 
Five day old Caco-2 cell monolayers were incubated with to 0mM, 2mM and 8mM of 
butyrate. Live microscopy was used to observe visual signs of cell apoptosis and death 
that included membrane blebbing, cell rounding and/or lifting [61]. The microscope was 
set to take images every 5 minutes using differential interference contrast (DIC) 
microscopy. As shown in Figure 5.2, the untreated and 2mM butyrate treated cell 
monolayers did not show any noticeable change in cell morphology over 25 hours. In 
contrast, exposure to 8mM sodium butyrate had a noticeable effect on the cells, with 
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Figure 5.2: Dose-dependent effect of butyrate on Caco-2 cell monolayers. Five day old 
Caco-2 monolayers were incubated in the presence of 0mM, 2mM and 8mM butyrate and 
differential interference contrast (DIC) images were taken over 25 hours. Images shown were 
taken at 5 hour intervals and are representative of one experiment. 
 
Despite inducing the highest levels of IAP activity, microscopy suggested that 8mM 
butyrate was causing the cell monolayers to disintegrate. Accordingly, five day 
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monolayers of Caco-2 cells were incubated with all three concentrations of butyrate. 
Cell numbers and viability were determined by counting cell numbers and the 
percentage of trypan blue-stained cells, respectively. Following exposure to 4mM 
butyrate, the number of Caco-2 cells per well was found to be similar to that of cells 
exposed to 20% (v/v) PF for the same period of time (Figure 5.4). Likewise, the 
percentage of dead cells was not higher in 4mM butyrate treated cells when compared 
to cell death rates in PF-treated cells (Figure 5.5). Accordingly, a concentration of 4mM 
butyrate was chosen as a control for the effectiveness of TEI-9647 in blocking the 
VDR.  
 
While butyrate was shown to be a more potent stimulator of IAP activity, vitamin D is 
still the physiological ligand to the vitamin D receptor and research by others suggests 
that it should have had a greater magnitude of effect [33]. For this reason, cell 
responses in the presence of 80nM vitamin D, the highest concentration tested, were 
also measured in the following experiments. 
 
5.3 TEI-9647 does not block PF-induced increase in IAP 
activity 
A 4mM concentration of butyrate and 80nM Vitamin D were used to stimulate IAP 
release by five day old monolayers of Caco-2 cells, with and without the addition of the 
VDR inhibitor TEI-9647. In addition, the ability of TEI-9647 to block IAP release by 
Caco-2 cells in response to 20% (v/v) PF was assessed. The TEI-9647 inhibitor was 
provided at a concentration of 1mM dissolved in ethanol with a recommended dilution 
of 1:1000 for cell culture experiments. To optimise the response and observe a dose 
response, TEI-9647 was used in these experiments at half (0.5µM) and at double 
(2µM) this concentration. Ethanol diluted 1/1000 reportedly has no significant effect on 
Caco-2 [33] but because some cells were incubated with VDRI at 2µM concentration, 
controls included cells exposed to a 1/500 dilution of ethanol in cell culture media, 
using the same experimental parameters. Cell numbers and viability in these ethanol 
controls did not differ from untreated cells (not shown). 
 
Treatment of Caco-2 cells with TEI-9647 was associated with a dose-dependent 
decrease in IAP activity in butyrate and vitamin D-stimulated cells (P<0.05), with this 
effect was most notable in the presence of butyrate (Figure 5.3). In contrast, the VDRI 
had no effect on IAP levels in Caco-2 cells following exposure to 20% (v/v) PF. 
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Figure 5.3: Effect of TEI-9647 on vitamin D, butyrate and PF stimulation of IAP activity. 
Caco-2 cells were exposed for 72 hours to 80nM Vitamin D, 4 mM butyrate and 20% (v/v) PF, 
without and without the addition of the VDRI at 0.5µM and 2µM, and IAP activity was measured 
in the cell lysate. Results are ± SEM of 3 independent experiments. Raw data for each 
treatment group were analysed separately by repeated measure ANOVA, and asterisks linked 
by bars indicate significant differences between the different concentrations of inhibitor within 
each group. *, P<0.05. 
 
 
5.4 TEI-9647 does not affect PF induced decrease in 
cell number 
The VDRI was capable of reducing IAP activity under all treatment conditions except 
PF. Butyrate and PF also cause changes in Caco-2 proliferation and viability which 
may involve cellular pathways also influenced by VDR. Any effect of the VDRI would 
be expected to reduce a PF or butyrate-induced decline in cell number and increase in 
cell death. 
 
80nM vitamin D caused a non-significant increase in cell number from around 0.34 
million cells per well to around 0.42 million cells. 4mM butyrate and 20% PF both 
caused cell number to drop to around 0.2 million cells, as expected from earlier 
experiments (Figure 5.1). TEI-9647 had no effect on PF, vitamin D or control cell 
number however a 50% reduction in cell number was observed in butyrate-treated 
cells incubated with 2µM VDRI (P<0.01). The significant effect of the VDRI on 4mM 
butyrate, without any change in response by PF treated cells, indicates that the VDR 
does not mediate PF-induced changes in cell proliferation. 
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Figure 5.4: Effect of VDRI TEI-9647 on caco-2 cell number in the presence of stimuli. 
Vitamin D (80nm), 4mM butyrate and 20% (v/v) polymeric formula were added to 5 day old 
Caco-2 monolayers for 72 hours without and without the addition of VDRI at 0.5µM and 2µM, 
and cell numbers were counted by haemocytometer. Results are ± SEM of 3 independent 
experiments. Raw data for each treatment group were analysed separately by repeated 
measure ANOVA, and asterisks linked by bars indicate significant differences between the 
different concentrations of inhibitor within each group. **, P<0.01. 
 
5.5 TEI-9647 has no effect on Caco-2 cell viability 
80nM Vitamin D treatment did not appear to affect cell viability, ranging between 5% 
and 10% as seen with untreated cells. 4mM butyrate caused an increase in cell death 
to 16%, while treatment with 20% PF resulted in approximately 21% of the cells dying. 
This PF-mediated increase in cell death was significant when compared to untreated 
controls (P<0.01; Figure 5.5).  
 
Addition of the VDRI had no apparent effect on the rate of cell death in untreated cells 
or cell treated with either 20% PF or 80nM vitamin D. However, increasing 
concentrations of TEI-9647 added to 4mM butyrate treated cells resulted in a notable 
decrease in cell death, and this is consistent with butyrate-induced cell death being 
mediated through the VDR (Figure 5.5). 
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Figure 5.5: VDRI TEI-9647 does not affect Caco-2 cell viability in the presence of stimuli. 
Vitamin D (80nM), 4mM butyrate and 20% (v/v) polymeric formula were added to 5 day old 
Caco-2 monolayers for 72 hours without and without the addition of the VDRI at 0.5µM and 
2µM, and cell viability was determined by trypan blue exclusion. Results are ± SEM of 3 
independent experiments. Raw data for each treatment group were analysed separately by 
repeated measure ANOVA. There were no significant differences between the different 




The first objective of these experiments was to determine suitable concentrations of 
vitamin D and butyrate to be used as positive controls for assessing the ability of TEI-
9647 to inhibit the VDR in Caco-2 cells. This was done by measuring increase in IAP 
activity after 72 hours and comparing the results with levels expressed by cells treated 
with 20% (v/v) PF. 
 
Both vitamin D and butyrate caused a dose-dependent increase in IAP activity. This 
increase was demonstrably clear with butyrate but, in marked contrast, the magnitude 
of the effect in cells stimulated with vitamin D was very small. This was unexpected as 
the concentrations of vitamin D used were within the range reported elsewhere in 
experiments using Caco-2 cells [51]. Additionally, the concentrations of vitamin D were 
similar to those which would be expected in cell medium containing 20% PF. This 
marked difference may have been due to a loss of biological activity in the vitamin D, 
either by oxidation, or through exposure to ultraviolet light. However, another 
possibility also exists. In some studies vitamin D has been found to have no or little 
effect on its own in affecting markers of epithelial function such as tight junctions or 
AMP expression, but capable of attenuating the effect of an inflammatory stimulus [20, 
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27]. Thus, the absence of NF-κB stimulation may have limited the stimulatory effect of 
vitamin D. 
 
The greatest increase in IAP activity was in cells treated with 8mM butyrate. However, 
subsequent experiments showed that this concentration of butyrate has a cytotoxic 
effect on Caco-2 cells. While untreated and 2mM treated cells showed little difference 
over 25 hours, DIC microscopy of 8mM butyrate showed a clear difference in cell 
morphology, with a loss of cells from the monolayer, rounding and blebbing of cell 
membranes. This was confirmed by cell number and viability counts. IAP activity was 
also substantially increased in Caco-2 cells treated with 4mM butyrate. Similar counts 
of 4mM butyrate-treated cells revealed that this concentration was no more toxic to 
Caco-2 cells that 20% (v/v) PF and this concentration was subsequently chosen for 
ongoing experiments. 
 
The second objective was to confirm that TEI-9647 is an effective VDRI in Caco-2 
cells, and to ascertain the contribution of the VDR to the observed PF induced pro-
differentiation response in these cells. The addition of TEI-9647 was shown to cause a 
significant decrease in IAP activity at 72 hours in the presence of either positive control 
(butyrate or vitamin D), and when added to untreated cells. This was most notable 
when the higher concentration of TEI-9647 was added to cells stimulated with 4mM 
butyrate, with IAP levels falling by approximately half. In marked contrast, the effect of 
20% PF on IAP levels was not affected at either VDRI concentration, which suggests 
that the VDR does not mediate the PF induced effect in Caco-2 cells. Ideally, this 
hypothesis would have been explored further by using increased concentrations of the 
VDRI. However, TEI-9647 was provided by the company as a solution in absolute 
ethanol, and the likelihood of an ethanol-mediated effect on the cells ruled out this 
approach.  
 
As well as IAP activity, cell proliferation had also been shown to change in the 
presence of PF. Cell proliferation increased with 80nM vitamin D but decreased with 
4mM butyrate, similar to that seen in Caco-2 cells treated with 20% PF. Treatment with 
TEI-9647 blocked the butyrate-mediated effect on cell growth, and this effect was 
observed to be concentration-dependent. In contrast, VDRI-treatment of Caco-2 cells 
did not override the inhibitory effect of 20% PF on cell proliferation. Also, the VDRI did 
not cause a significant change in rates of cell death. 
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This lack of response of PF-treated Caco-2 cells to VDR inhibition may provide an 
explanation as to why 10nM vitamin D is shown to cause an increase in Caco-2 cell 
migration [51] whereas treatment with 20% PF as the stimuli showed the opposite 
effect (Chapter 3). Likewise, Vitamin D treatment was shown to cause opposing 
changes to cell proliferation, an important factor in the rate of Caco-2 cell spread. 
Collectively, these results suggest that it is unlikely that the observed effect of PF on 
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Chapter 6. Discussion 
 
6.1 Summary of results 
As shown in other studies, Caco-2 cells were found to spontaneously differentiate and 
display many of the characteristics of enterocytes that included the formation of an 
adherent monolayer and expression of IAP [30, 39]. With two different seeding 
concentrations, 5 x 104 and 1 x 105 cells per 2cm2 well, the cells initially underwent a 
phase of rapid proliferation. After 5 to 6 days an increase in cell density and contact 
inhibition prompted the cells to differentiate. The concentration of non-viable cells 
varied between 5% and 10%, and did not increase with time. 
 
Measurement of IAP activity was used as a known marker of Caco-2 differentiation 
[28, 30]. Levels in both membrane and secreted fractions increased as cell numbers 
increased, and continued to increase as cellular proliferation slowed with the start of 
differentiation. Total IAP activity was much higher in the supernatant when compared 
to the corresponding cell lysates, which is consistent with directed IAP secretion. 
However due to the extensive dilution in the cell medium, changes in secreted IAP 
activity were more difficult to detect. This was further compounded when investigating 
the effect of the highly opaque polymeric formula (PF). 
 
Seeding each well with 1 x 105 cells and incubating for a period of five days was 
chosen as the time-point at which to add stimuli. At this point the cells had formed a 
confluent monolayer but were only partially differentiated so could still respond to pro-
differentiation stimuli. Treatment with 20% (v/v) polymeric formula (PF) over 72 hours 
resulted in a 50% decrease in cell number. PF was also shown to cause a 44% 
inhibition of cell migration over 18 days, which can be attributable to the decrease in 
Caco-2 cell proliferation. By 72 hours there was also a threefold increase in cell death, 
which was shown to be related to increased apoptosis over the first 10 hours rather 
than toxic necrosis. This increase in apoptosis is consistent with an increased rate of 
differentiation as apoptosis and exfoliation from the tip of the villus is the end stage in 
enterocyte differentiation, to make way for newly differentiated cells. Acceleration of 
this process was supported by the increase in IAP activity and protein expression with 
PF treatment. This was statistically significant by 48 hours and showed a further 
increase at 72 hours.  
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An additional model of small intestine epithelium was developed, the enteroid. Stem 
cell rich crypts were harvested from mice, as these are both easier to obtain and have 
higher rates of success than human biopsy enteroids [47]. The mouse crypts were 
incubated within an extracellular matrix; nutrients and growth factors were added to the 
culture medium to stimulate stem cell proliferation and survival. These crypts were 
found to close over and become cysts over the first day, then to increase in size to 
between 0.2 and 0.3 mm and generate new crypts from a central lumen. Enteroids are 
more similar to normal intestinal epithelium than Caco-2 cells as they contain the full 
range of cell types that produce the enzymes, mucus and anti-microbial peptides 
present in a functioning intestine [26]. In these enteroids, mucus secreting goblet cells 
could be identified by their characteristic shape, and AMP producing Paneth cells 
could be identified by their location at the base of crypts and due to their darker 
appearance under bright-field microscopy. However between 10 days and 3 weeks the 
enteroids no longer increased in size or complexity despite replacement of growth 
factors every 2 days. For this reason, day 10 was chosen as an appropriate time point 
for investigation of the effect of 20% (v/v) PF in the enteroid model. 
 
Within hours of PF treatment, the enteroid structures disintegrated into loose 
aggregates of cells. This occurred much more rapidly than the effects of PF on Caco-2 
cells, which occurred over two to three days. Changes in the pattern of IAP protein 
expression were observed using confocal microscopy, where 6 hours of 20% PF 
treatment resulted in a granular pattern of staining while untreated enteroids had a 
more uniform signal. Almost all layers of the PF-treated enterocytes dissociated into 
clusters of non-polarised cells, which was similar to what was observed when 
enteroids were briefly deprived of necessary growth factors. The lead to the hypothesis 
that reduced activity of the Wnt signalling pathway may be involved. PF causes a 
delay in degradation of IκBα, which binds to NF-κB and prevents it from translocating 
to the cell nucleus where it causes up-regulation of pro-inflammatory gene expression 
(de Jong). The Wnt cellular pathway has been shown to be promoted by an increase in 
NF-κB activity [53], thus the reduced proliferation and pro-differentiation effects of PF 
could be mediated by a reduction in NF-κB and Wnt downstream effectors. 
 
Growing mouse crypts on a collagen layer rather than within a matrix was attempted in 
order to develop a two dimensional primary cell monolayer model. Collagen grown 
enteroids are similar to those immersed in Matrigel in that they reportedly contain 
multiple types of self-regenerating and differentiating cells and are therefore 
representative of normal intestinal epithelium [46, 54]. It was speculated that this 
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model might even be potentially more relevant when experimenting with dietary 
treatments with the ability to add stimuli to the luminal surface, as would occur in vivo 
However the stem cells did not proliferate and form monolayers over the collagen 
surface despite having the enteroid growth factors present in the cell medium. This 
remains to be investigated. 
 
Vitamin D was considered as a contributor to the mechanism of PF as it has been 
shown to have similar effects. These include inhibition of IκBα degradation, down-
regulation of inflammatory cytokine production [20, 23, 43] and an increase in IAP 
activity [33]. Vitamin D deficiency is commonly seen in CD, of which PF is a treatment 
[20, 51, 55, 56]. The VDR mediates most known functions of vitamin D [56], and a 
VDR antagonist was obtained to determine inhibition of the VDR would likewise inhibit 
the effects of PF. 
 
Vitamin D and butyrate were used as a positive controls for determining the 
effectiveness of VDR inhibition with TEI-9647. Both are known to promote enterocyte 
differentiation through the VDR [33, 39, 56]. A dose response effect on IAP activity 
after 72 hours was used to determine the optimum concentrations. The highest 
concentration of butyrate, 8mM, resulted in the greatest increase in IAP activity, 
however this occurred at the expense of cell viability, which was shown to be markedly 
affected within 25 hours of exposure. 4mM of butyrate stimulated a large increase in 
IAP activity but without the corresponding increase in cell death. 
 
TEI-9647 did not affect cell viability in the presence of any of the cell treatments. Yet it 
halved the effect of 4mM butyrate on cell proliferation and IAP activity. This effect was 
significant and displayed a dose response. TEI-9647 also caused a significant 
decrease in IAP activity in both 80nM vitamin D treated and untreated cells. In 
contrast, the presence of TEI-9647 had no effect on PF-mediated cell proliferation 
and/or IAP activity, indicating that the accelerated differentiation of Caco-2 cells in the 
presence of PF is not primarily mediated through the vitamin D receptor. 
 
6.2 Future directions 
In order to further understand the interactions between PF and enterocyte 
differentiation, these experiments need to be retested with a more complete model that 
would include knocking out the VDR through the use of RNA interference, gene 
knockout or use of a stronger antagonist. Additional inhibition of NF-κB and/or Wnt 
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signalling would support or dispel the hypothesis that reduced activation of this cellular 
cascade is mediating the effects seen in both Caco-2 and enteroids.  
 
Further development of the enteroid model is also necessary, with a greater 
understanding of the cause(s) of its limitations required to enable more realistic 
interactions to occur. This work is underway, starting with a project aimed at 
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